等待開盤 08-21 09:30:00 美东时间
-2.925
-1.36%
As the Q2 earnings season draws to a close, investors are turning their attention to broader metrics to identify sustainable market leaders. With corporate report cards nearly finalized, assessing yea...
08-17 20:26
情理之中,意料之外。 8月10日晚间,一则License-in消息引爆医药圈——百济神州宣布与Revolution Medicines达成临床联合开发与区域商业...
08-14 13:38
今日重点评级关注:Truist Securities:维持AbCellera Biologics"买入"评级,目标价从12美元升至30美元;Stifel:维持Proficient Auto Logistics"买入"评级,目标价从9美元升至12美元
08-12 08:45
Erasca reported positive updated clinical data for ERAS-0015 in 2L+ KRAS G12X pancreatic and lung cancers, with a 57% objective response rate and favorable tolerability. The company secured $632 million in financing, strengthening its balance sheet to $384 million. Key upcoming milestones include Phase 1 data in H1 2027 and potential registration-enabling trials for pancreatic and lung cancers.
08-11 20:01
8月11日上午,百济神州(ONC.US、06160.HK、688235.SH)A股以及港股股价涨幅超过4%,其中A股市值达到4820亿元。 盘面上,公司...
08-11 12:49
8月11日,百济神州(06160.HK)早盘涨超4%,截至发稿,涨2.72%,报219港元,成交额2.97亿港元。 消息面上,8月10日,据百济神州官微消息,公...
08-11 09:49
(来源:药研网) 刚刚,百济神州(BeOne Medicines)与临床后期肿瘤公司Revolution Medicines共同宣布,双方达成一项涵盖临床联...
08-10 18:50
根据美国证券交易委员会(SEC)文件披露,谷歌母公司Alphabet Inc.将其持有Revolution Medicines Inc.的股份削减10.5%,减...
08-07 18:07